AVB-101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVB-101, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN) [Phase 1, Phase 2]